Ferritin, a complex of ferric (Fe2+) hydroxide and a protein, apoferritin, originates in the reticuloendothelial system. Ferritin reflects the body iron stores and is the most reliable indicator of total-body iron status. A bone marrow examination is the only better test. Bone marrow aspiration may be necessary in some cases, such as low-normal ferritin and low serum iron in the anemia of chronic disease.
The ferritin test is more specific and more sensitive than iron concentration or TIBC for diagnosing iron deficiency. Ferritin decreases before anemia and other changes occur (see Table 2.6).
Men: 18270 ng/mL or 18270 μg/L
With anemia of chronic disease: <100 ng/mL or <100 μg/L
In absence of inflammation: <20 ng/mL or <20 μg/L
Women: 18160 ng/mL or 18160 μg/L
With anemia of chronic disease: <20 ng/mL or <20 μg/L
In absence of inflammation: <10 ng/mL or <10 μg/L
Children: 7140 ng/mL or 7140 μg/L
Newborns: 25200 ng/mL or 25200 μg/L
1 month: 50200 ng/mL or 50200 μg/L
25 months: 50200 ng/mL or 50200 μg/L
Serum TfRferritin index: 1.5 in absence of anemia of chronic disease, 0.8 with anemia of chronic disease
TfR is the transferrin receptor.
Clinical Alert
Critical ValueIron deficiency: 10 ng/mL or 10 g/L
Obtain a venous sample of 6 mL using a red-topped tube or SST. Label the specimen with the patients name, date and time of collection, and test(s) ordered.
Place the specimen in a biohazard bag.
Decreased ferritin (<10 ng/mL or <10 μg/L) usually indicates iron-deficiency anemia.
Increased ferritin (>400 ng/mL or >400 μg/L) occurs in iron excess and in the following:
Iron overload from hemochromatosis or hemosiderosis
Oral or parenteral iron administration
Inflammatory diseases
Acute or chronic liver disease involving alcoholism
Acute myoblastic or lymphoblastic leukemia
Other malignancies (Hodgkin disease, breast carcinoma, malignant lymphoma)
Hyperthyroidism
Hemolytic anemia, megaloblastic anemia, thalassemia, sideroblastic anemia
Renal cell carcinoma, end-stage renal disease
Pretest Patient Care
Explain test purpose and procedure. Fasting is not necessary. Assess for signs/symptoms of dyspnea; fatigue; listlessness; pallor; loss of consciousness; irritability; headache; tachycardia; brittle, spoon-shaped nails; and cracks at the corners of the mouth.
Radioactive medications may not be given for 34 days before testing.
Refrain from alcohol (higher levels of ferritin occur in alcoholism).
Follow guidelines in Chapter 1 for safe, effective, informed pretest care.
Posttest Patient Care
Have the patient resume normal activities.
Review test results; report and record findings. Modify the nursing care plan as needed. Counsel the patient regarding abnormal findings; explain the need for possible follow-up testing and treatment. Monitor for iron-deficiency anemia and ferritin increases. When iron and TIBC tests are used together with ferritin, they can better distinguish between iron-deficiency anemia and the anemia of chronic disease. Treatment may include VB12 and folic acid.
Follow guidelines in Chapter 1 for safe, effective, informed posttest care.
Recently administered radioactive medications cause spurious results.
Oral contraceptives and antithyroid therapy interfere with testing (see Appendix E).
Hemolyzed blood may cause high results.
Increases with age.
Higher in red meat eaters than in vegetarians.
Ferritin is not of value to evaluate iron stores in persons with alcoholism who have liver disease.